Reuters - Video

Edition: US | UK | IN | CN | JP

video Business

Bayer profit flat as weak animal health offsets strong Xarelto

Tuesday, November 13, 2018 - 01:29

Bayer's adjusted core earnings were flat for the quarter, as better prescription numbers for cardiovascular drug Xarelto were tempered by a weaker animal health business and a strong euro weighing on the value of overseas sales. Sonia Legg reports.

▲ Hide Transcript

View Transcript

Bayer's adjusted core earnings were flat for the quarter, as better prescription numbers for cardiovascular drug Xarelto were tempered by a weaker animal health business and a strong euro weighing on the value of overseas sales. Sonia Legg reports.

Press CTRL+C (Windows), CMD+C (Mac), or long-press the URL below on your mobile device to copy the code

Bayer profit flat as weak animal health offsets strong Xarelto

Tuesday, November 13, 2018 - 01:29